المؤلفون: Roh S; Department of Plastic Surgery, Asahi General Hospital, Japan., Hashimoto K; Department of Plastic Surgery, Asahi General Hospital, Japan., Kiriishi R; Department of Plastic Surgery, Asahi General Hospital, Japan., Matsubara K; Department of Plastic Surgery, Asahi General Hospital, Japan., Isozaki Y; Department of Plastic Surgery, Asahi General Hospital, Japan., Tanaka H; Department of Hematology, Asahi General Hospital, Japan., Kuwata T; Department of Plastic Surgery, Asahi General Hospital, Japan.

المصدر: Journal of wound care [J Wound Care] 2024 Jun 01; Vol. 33 (Sup6), pp. S25-S30.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: MA Healthcare Country of Publication: England NLM ID: 9417080 Publication Model: Print Cited Medium: Internet ISSN: 0969-0700 (Print) Linking ISSN: 09690700 NLM ISO Abbreviation: J Wound Care Subsets: MEDLINE

مواضيع طبية MeSH: Pressure Ulcer*/drug therapy , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Osteomyelitis*/drug therapy , Thrombocytopenia*/chemically induced , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use, Humans ; Male ; Middle Aged ; Piperacillin/adverse effects ; Piperacillin/therapeutic use ; Pseudomonas Infections/drug therapy ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/adverse effects ; Penicillanic Acid/therapeutic use ; Debridement

المؤلفون: Ide N; Department of Practical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan; n-ide@nichiyaku.ac.jp., Sako KI; Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan., Takigawa M; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan., Tanaka H; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 May-Jun; Vol. 38 (3), pp. 1436-1442.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Vancomycin*/adverse effects , Vancomycin*/administration & dosage , Acute Kidney Injury*/chemically induced , Acute Kidney Injury*/epidemiology , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage , Drug Therapy, Combination*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Incidence ; Pharmacovigilance ; Databases, Factual ; Aged, 80 and over ; Risk Factors

المؤلفون: Roehmel JF; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), associated partner site, Berlin, Germany. Electronic address: jobst.roehmel@charite.de., Rohrbach A; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Staab D; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Mall MA; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), associated partner site, Berlin, Germany., Ogese M; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, UK., Doerfler F; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Naisbitt D; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, UK.

المصدر: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 May; Vol. 23 (3), pp. 573-578. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE

مواضيع طبية MeSH: Cystic Fibrosis*/drug therapy , Cystic Fibrosis*/immunology , Drug Hypersensitivity*/diagnosis , Drug Hypersensitivity*/etiology , Drug Hypersensitivity*/immunology , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Skin Tests*/methods , Piperacillin*/adverse effects , Piperacillin*/administration & dosage , Hypersensitivity, Delayed*/diagnosis , Hypersensitivity, Delayed*/etiology , Hypersensitivity, Delayed*/immunology, Humans ; Male ; Female ; Prospective Studies ; Adult ; Lymphocyte Activation/drug effects ; Adolescent ; Child ; Predictive Value of Tests ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/adverse effects ; Penicillanic Acid/administration & dosage ; Young Adult

المؤلفون: Aggarwal P; Department of Microbiology, Maulana Azad Medical & Associated Lok Nayak Hospital, New Delhi, 110002, India. Electronic address: prabhavaggarwal@yahoo.co.in., Saxena S; Department of Microbiology, Maulana Azad Medical & Associated Lok Nayak Hospital, New Delhi, 110002, India. Electronic address: sonalsaxena3@gmail.com., Nagi N; Department of Microbiology, Maulana Azad Medical & Associated Lok Nayak Hospital, New Delhi, 110002, India. Electronic address: nazia.nagi@gmail.com.

المصدر: Indian journal of medical microbiology [Indian J Med Microbiol] 2024 May-Jun; Vol. 49, pp. 100602. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8700903 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-3646 (Electronic) Linking ISSN: 02550857 NLM ISO Abbreviation: Indian J Med Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Piperacillin, Tazobactam Drug Combination*/pharmacology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Pseudomonas aeruginosa*/drug effects , Aminoglycosides*/pharmacology, Humans ; India ; Disk Diffusion Antimicrobial Tests/methods ; Enterobacteriaceae/drug effects ; Microbial Sensitivity Tests ; Amikacin/pharmacology

المؤلفون: Nishiyama M; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Takeda S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Watanabe Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Iida M; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Yamamoto T; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Nakashima C; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Matsui H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Shindo Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Tokumitsu Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Tomochika S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Ioka T; Oncology Center, Yamaguchi University Hospital, Ube, Japan., Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan; hnagano@yamaguchi-u.ac.jp.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1790-1798.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Esophagectomy*/adverse effects , Esophagectomy*/methods , Esophageal Neoplasms*/surgery , Pneumonia*/prevention & control , Pneumonia*/etiology , Pneumonia*/epidemiology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Postoperative Complications*/prevention & control , Postoperative Complications*/etiology, Humans ; Male ; Female ; Aged ; Middle Aged ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/administration & dosage ; Retrospective Studies ; Risk Factors

المؤلفون: Chanderraj R; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Medicine Service, Infectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan., Admon AJ; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor., He Y; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor., Nuppnau M; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor., Albin OR; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan., Prescott HC; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.; Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.; Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan., Dickson RP; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor., Sjoding MW; Weil Institute for Critical Care Research & Innovation, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.; Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor.

المصدر: JAMA internal medicine [JAMA Intern Med] 2024 Jul 01; Vol. 184 (7), pp. 769-777.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Cefepime*/administration & dosage , Cefepime*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Sepsis*/drug therapy , Sepsis*/mortality, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged

المؤلفون: Hardy M; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia., Harris PNA; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Central Microbiology Laboratory, Pathology Queensland, Brisbane, Queensland, Australia., Paterson DL; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.; Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Chatfield MD; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia., Mo Y; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

مؤلفون مشاركون: MERINO Trial Investigators

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1482-1489.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Meropenem*/therapeutic use , Meropenem*/pharmacology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Klebsiella pneumoniae*/drug effects , Piperacillin*/therapeutic use , Piperacillin*/pharmacology , Klebsiella Infections*/drug therapy , Klebsiella Infections*/mortality, Humans ; Bacteremia/drug therapy ; Bacteremia/microbiology ; Bacteremia/mortality ; Escherichia coli/drug effects ; Escherichia coli Infections/drug therapy ; Escherichia coli Infections/microbiology ; Escherichia coli Infections/mortality ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/therapeutic use ; Penicillanic Acid/pharmacology ; Ceftriaxone/therapeutic use ; Ceftriaxone/pharmacology ; Male ; Female ; Middle Aged ; Thienamycins/therapeutic use ; Thienamycins/pharmacology ; Aged ; Treatment Outcome

المؤلفون: Serrano-Mayorga CC; Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia.; School of Medicine, Universidad de La Sabana, Chía, Colombia.; Clinica Universidad de La Sabana, Chía, Colombia.; Engineering Faculty, Universidad de La Sabana, Chía, Colombia., Duque S; Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia., Ibáñez-Prada ED; Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia.; School of Medicine, Universidad de La Sabana, Chía, Colombia.; Clinica Universidad de La Sabana, Chía, Colombia., Garcia-Gallo E; Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia.; Pandemic Sciences Institute, University of Oxford, Oxford, UK., Arrieta MPR; School of Medicine, Universidad de La Sabana, Chía, Colombia., Bastidas A; School of Medicine, Universidad de La Sabana, Chía, Colombia., Rodríguez A; ICU Hospital , Universitario de Tarragona Joan XXIII - IISPV - Universidad Rovira and Virgili - CIBERES, Tarragona, Spain., Martin-Loeches I; Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin, Ireland.; Trinity College Dublin, Dublin, Ireland.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Pulmonary Department, Hospital Clinic, Universitat de Barcelona, IDIBAPS, ICREA, Barcelona, Spain., Reyes LF; Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia. luis.reyes5@unisabana.edu.co.; School of Medicine, Universidad de La Sabana, Chía, Colombia. luis.reyes5@unisabana.edu.co.; Clinica Universidad de La Sabana, Chía, Colombia. luis.reyes5@unisabana.edu.co.; Pandemic Sciences Institute, University of Oxford, Oxford, UK. luis.reyes5@unisabana.edu.co.

المصدر: Scientific reports [Sci Rep] 2024 Jun 11; Vol. 14 (1), pp. 13392. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Cefepime*/therapeutic use , Cefepime*/administration & dosage , Community-Acquired Infections*/drug therapy , Community-Acquired Infections*/mortality , Critical Illness* , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/therapeutic use , Intensive Care Units*, Humans ; Male ; Female ; Aged ; Middle Aged ; Likelihood Functions ; Pneumonia/drug therapy ; Pneumonia/mortality ; Piperacillin/therapeutic use

المؤلفون: Mourad A; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham 27710, NC, USA., Smith AG; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Troy JD; Division of Biostatistics, Department of Biostatics & Bioinformatics, Duke University, Durham, NC, USA., Holland TL; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham 27710, NC, USA., Wrenn RH; Department of Pharmacy, Duke University Medical Center, Durham, NC, USA., Turner NA; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham 27710, NC, USA.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jun 03; Vol. 79 (6), pp. 1456-1461.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Ceftriaxone*/therapeutic use , Ceftriaxone*/pharmacology , Klebsiella pneumoniae*/drug effects , Klebsiella pneumoniae*/isolation & purification , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/pharmacology , Escherichia coli*/drug effects , Escherichia coli*/isolation & purification , Bacteremia*/drug therapy , Bacteremia*/microbiology , Bacteremia*/mortality , Klebsiella Infections*/drug therapy , Klebsiella Infections*/microbiology , Klebsiella Infections*/mortality , Escherichia coli Infections*/drug therapy , Escherichia coli Infections*/microbiology , Microbial Sensitivity Tests*, Humans ; Middle Aged ; Male ; Female ; Retrospective Studies ; Aged ; Treatment Outcome

المؤلفون: Racketa S; AdventHealth Daytona Beach, Department of Pharmacy, 301 Memorial Medical Pkwy., Daytona Beach, FL 32117, USA. Electronic address: savannah.racketa@adventhealth.com., Gandhi K; AdventHealth Daytona Beach, Department of Pharmacy, 301 Memorial Medical Pkwy., Daytona Beach, FL 32117, USA., Lambie M; AdventHealth Daytona Beach, Department of Pharmacy, 301 Memorial Medical Pkwy., Daytona Beach, FL 32117, USA.

المصدر: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Jun; Vol. 109 (2), pp. 116209. Date of Electronic Publication: 2024 Feb 10.

نوع المنشور: Journal Article; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn Microbiol Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Meropenem*/therapeutic use , Meropenem*/administration & dosage , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Pancreatitis, Acute Necrotizing/drug therapy ; Adult ; Treatment Outcome